IJ
Therapeutic Areas
Khondrion Pipeline
| Drug | Indication | Phase |
|---|---|---|
| sonlicromanol | Primary Mitochondrial Disease (m.3243A>G mutation) - MELAS, MIDD, CPEO, mixed phenotypes | Phase 3 |
| Drug | Indication | Phase |
|---|---|---|
| sonlicromanol | Primary Mitochondrial Disease (m.3243A>G mutation) - MELAS, MIDD, CPEO, mixed phenotypes | Phase 3 |